Akira Tsuji

9.3k total citations · 2 hit papers
218 papers, 7.4k citations indexed

About

Akira Tsuji is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Akira Tsuji has authored 218 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 56 papers in Molecular Biology and 42 papers in Pharmacology. Recurrent topics in Akira Tsuji's work include Drug Transport and Resistance Mechanisms (46 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Amino Acid Enzymes and Metabolism (25 papers). Akira Tsuji is often cited by papers focused on Drug Transport and Resistance Mechanisms (46 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Amino Acid Enzymes and Metabolism (25 papers). Akira Tsuji collaborates with scholars based in Japan, United States and United Kingdom. Akira Tsuji's co-authors include Ikumi Tamai, Yoshimichi Sai, Tsukinaka Yamana, Jun‐ichi Nezu, Miyuki Shimane, Asuka Oku, Rikiya Ohashi, Tetsuya Terasaki, Hikaru Yabuuchi and Hiroshi Uchino and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Akira Tsuji

212 papers receiving 7.1k citations

Hit Papers

Molecular and Functional ... 1998 2026 2007 2016 1998 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Tsuji Japan 44 3.0k 2.5k 1.5k 1.5k 963 218 7.4k
Hideyuki Saito Japan 55 4.9k 1.6× 2.5k 1.0× 877 0.6× 2.6k 1.8× 1.3k 1.3× 273 9.5k
Takeo Nakanishi Japan 51 3.2k 1.1× 2.7k 1.1× 660 0.4× 1.1k 0.7× 1.3k 1.4× 206 7.2k
Gerhard Burckhardt Germany 41 2.8k 0.9× 2.6k 1.0× 761 0.5× 1.3k 0.9× 761 0.8× 164 6.3k
Toshimitsu Niwa Japan 60 1.2k 0.4× 4.1k 1.6× 2.5k 1.7× 701 0.5× 705 0.7× 311 13.0k
Gert Fricker Germany 56 4.2k 1.4× 3.3k 1.3× 305 0.2× 1.9k 1.3× 343 0.4× 258 10.6k
Irwin M. Arias United States 58 3.4k 1.1× 4.4k 1.7× 916 0.6× 2.8k 1.9× 621 0.6× 196 10.0k
Masahiro Okuda Japan 36 2.1k 0.7× 1.2k 0.5× 406 0.3× 1.3k 0.9× 491 0.5× 193 5.3k
Akira Yoshida Japan 57 1.1k 0.4× 5.4k 2.1× 808 0.5× 1.4k 0.9× 874 0.9× 507 12.6k
W. Gerok Germany 51 1.9k 0.6× 2.7k 1.1× 948 0.6× 516 0.4× 714 0.7× 379 10.0k
Tomohiro Terada Japan 48 3.1k 1.0× 1.9k 0.7× 248 0.2× 1.2k 0.8× 862 0.9× 229 6.2k

Countries citing papers authored by Akira Tsuji

Since Specialization
Citations

This map shows the geographic impact of Akira Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Tsuji more than expected).

Fields of papers citing papers by Akira Tsuji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Tsuji. The network helps show where Akira Tsuji may publish in the future.

Co-authorship network of co-authors of Akira Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Tsuji. A scholar is included among the top collaborators of Akira Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Tsuji. Akira Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yoshizaki, Tomokazu, Akira Tsuji, & Shigeyuki Murono. (2009). Treatment of Recurrent Laryngeal Papillomatosis with Anti-viral Drug Cidofovir. Nihon Kikan Shokudoka Gakkai Kaiho. 60(4). 344–347.
3.
Tsuji, Akira, Naohiro Wakisaka, Satoru Kondo, et al.. (2008). Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma. Clinical Cancer Research. 14(17). 5368–5375. 40 indexed citations
4.
Tsuji, Akira. (2007). Can we predict pharmacokinetic profiles of drugs in humans from data of experimental animals?. Drug Delivery System. 22(1). 43–47. 2 indexed citations
5.
Kato, Yukio, et al.. (2004). PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2. Molecular Pharmacology. 67(3). 734–743. 67 indexed citations
6.
Teramachi, Hitomi, et al.. (2002). Comparative Examination of the Initial Dosage Setting of Vancomycin Therapy in the Adult MRSA Patients.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(6). 530–540. 6 indexed citations
7.
Yoshimura, Ichiro, et al.. (2001). IMMUNOHISTOCHEMICAL STUDY OF p53 AND Ki-67 OVEREXPRESSION IN GRADE 3 SUPERFICIAL BLADDER TUMOR IN RELATIONSHIP TO TUMOR RECURRENCE AND PROGNOSIS. The Japanese Journal of Urology. 92(7). 656–665. 2 indexed citations
8.
Mochizuki, Kiyofumi, et al.. (2000). Effects of Oral Kallidinogenase on Fundus and Retrobulbar Blood Flow in Retinal Vein Occlusion. 17(10). 1433–1436. 1 indexed citations
9.
Tamai, Ikumi, et al.. (2000). . KAGAKU TO SEIBUTSU. 38(7). 432–438. 1 indexed citations
10.
Tamai, Ikumi, Junko Yamashita, Yasuto Kido, et al.. (2000). Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 295(1). 146–152. 70 indexed citations
11.
Hashimoto, Noriyoshi, Fumio Suzuki, Ikumi Tamai, et al.. (1998). Gene-Dose Effect on Carnitine Transport Activity in Embryonic Fibroblasts of JVS Mice as a Model of Human Carnitine Transporter Deficiency. Biochemical Pharmacology. 55(10). 1729–1732. 32 indexed citations
12.
Sai, Yoshimichi, Ikumi Tamai, Haruhiro Higashida, et al.. (1996). Development of screening system for oral drug delivery of .BETA.-lactam antibiotics using a clone of intestinal oligopeptide transporter.. Drug Delivery System. 11(3). 205–213. 1 indexed citations
13.
Tsuji, Akira, et al.. (1996). The Effect of the Ortho-Bonding Unit in Novolak on the Photoresist.. KOBUNSHI RONBUNSHU. 53(4). 231–238. 4 indexed citations
14.
Kimura, Fumihiro, et al.. (1995). EXPRESSION OF GP160 mRNA IN RENAL CELL CARCINOMA: AN ATTEMPT TO PREDICT THE SENSITIVITY OF IFN-^|^alpha; THERAPY. The Japanese Journal of Urology. 86(9). 1424–1428. 1 indexed citations
15.
Nagata, Osamu, et al.. (1988). Disposition and metabolism of NY-198. IV. Absorption, distribution and excretion of 14C-NY-198 in rats and dogs. Chemotherapy. 36. 151–173. 9 indexed citations
16.
Nagata, Osamu, et al.. (1988). Disposition and metabolism of NY-198 V. Metabolism of 14c-ny-198 in rats and dogs. Chemotherapy. 36(2). 174–187. 3 indexed citations
17.
Makino, Eiichi, et al.. (1988). Disposition and metabolism of NY-198 II. Hplc and bioassay studies of absorption and excretion in the dog. Chemotherapy. 36. 138–143. 8 indexed citations
18.
Takahashi, Yoshie, et al.. (1988). Bioassay study of absorption, distribution and excretion of NY-198 compared with norfloxacin and ofloxacin. Chemotherapy. 36. 188–194. 2 indexed citations
19.
Tamai, Ikumi, et al.. (1987). INTESTINAL UPTAKE OF β-LACTAM ANTIBIOTICS WITHOUT AN α-AMINO GROUP AND ITS RELATIONSHIP TO DIPEPTIDE TRANSPORT. Journal of Pharmacobio-Dynamics. 10(4). 6 indexed citations
20.
Nakashima, Emi, Hitoshi Mizuo, Akira Tsuji, & Tsukinaka Yamana. (1983). CARRIER-MEDIATED TRANSPORT MECHANISM IN THE RAT INTESTINAL ABSORPTION OF AMINO-β-LACTAM ANTIBIOTICS. Journal of Pharmacobio-Dynamics. 6(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026